Senti Biosciences Inc SNTI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/24/24 EDT
0.33quote price arrow down-0.0101 (-2.9697%)
Volume
1,858
Close
0.3401quote price arrow down-0.0109 (-3.1054%)
Volume
77,353
52 week range
0.27 - 1.10
Loading...
  • Open0.3532
  • Day High0.3638
  • Day Low0.3122
  • Prev Close0.351
  • 52 Week High1.10
  • 52 Week High Date06/14/23
  • 52 Week Low0.27
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap15.561M
  • Shares Out45.76M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.89
  • YTD % Change-48.47

KEY STATS

  • Open0.3532
  • Day High0.3638
  • Day Low0.3122
  • Prev Close0.351
  • 52 Week High1.10
  • 52 Week High Date06/14/23
  • 52 Week Low0.27
  • 52 Week Low Date10/27/23
  • Market Cap15.561M
  • Shares Out45.76M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.89
  • YTD % Change-48.47

RATIOS/PROFITABILITY

  • EPS (TTM)-1.93
  • P/E (TTM)-0.18
  • Fwd P/E (NTM)-1.48
  • EBITDA (TTM)-68.40M
  • ROE (TTM)-102.25%
  • Revenue (TTM)1.275M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-6,753.80%
  • Debt To Equity (MRQ)0.18%

EVENTS

  • Earnings Date09/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Senti Biosciences Inc

 

Profile

MORE
Senti Biosciences, Inc. is a clinical-stage biotechnology company. It is developing cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. It is focused on off-the-shelf CAR-NK cell therapy programs for oncology indications. Its lead product candidate, SENTI-202, is a potential Logic Gated off-the-shelf CAR-NK cell therapy designed to selectively target and eliminate CD33 and/or FLT3 expressing hematologic...
Timothy Lu M.D., Ph.D.
Chief Executive Officer, Director
Kanya Rajangam M.D., Ph.D.
President, Head - Research and Development, Chief Medical Officer
Yvonne Li
Interim Chief Financial Officer
Address
2 Corporate Drive, First Floor
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
SYBX
Synlogic Inc
1.60+0.02+1.27%
GYRE
Gyre Therapeutics Inc
11.99-0.62-4.92%
SLGL
Sol Gel Technologies Ltd
0.791-0.009-1.125%
LUMO
Lumos Pharma Inc
2.45-0.05-1.96%
TFFP
TFF Pharmaceuticals Inc
2.22+0.18+8.82%